nib Holdings divests World Nomads to SiriusPoint subsidiary for $67.5 million
nib Holdings has signed a binding agreement for the nib Holdings World Nomads sale to International Medical Group (IMG), a wholly-owned subsidiary of SiriusPoint Ltd, for cash consideration of $67.5 million AUD. Net cash realisation on the transaction is expected to be around $70 million AUD, subject to customary completion adjustments.
The transaction includes the World Nomads international brand only. Critically, the sale does not encompass any other nib Travel assets, brands, partners, or business based in Australia or New Zealand. The purchase consideration is expected to be materially in line with the carrying value of the assets as at completion, with the majority of proceeds from the sale expected in CY26, subject to regulatory approvals and conditions.
SiriusPoint Ltd (NYSE: SPNT) is a global underwriter of insurance and reinsurance, whilst IMG is a leading provider of global insurance benefits and assistance services with more than 35 years’ experience supporting travellers, expatriates, and international workers.
Why travel insurance divestments matter for diversified insurers
Portfolio simplification represents a strategic tool for insurers seeking to sharpen operational focus and improve capital efficiency. Insurers often expand into adjacent segments during growth phases, but divesting non-core assets allows management to redirect resources toward higher-performing or strategically aligned businesses.
For investors, divestments signal capital allocation discipline. When an insurer sells a peripheral business at or near carrying value, it preserves balance sheet integrity whilst unlocking capital for redeployment. This can lead to improved return on equity when proceeds are directed to core competencies or returned to shareholders. Reduced portfolio complexity also enhances earnings visibility, making it easier for investors to assess underlying performance without distortions from smaller, lower-margin segments.
World Nomads’ contribution to nib Group
nib Travel accounted for $6.7 million of nib’s total Group underlying operating profit (UOP) of $239.2 million in FY25. World Nomads represents the international portion of this travel insurance segment, positioning it as a modest contributor to group earnings. The sale allows nib to simplify its portfolio without materially impacting overall profitability.
| Metric | FY25 Figure |
|---|---|
| nib Travel UOP | $6.7m |
| Group UOP | $239.2m |
| Travel as % of Group | ~2.8% |
The divestment reflects nib’s strategic priority to focus capital and capability on its core health insurance and health-adjacent businesses in the Australian and New Zealand markets.
Strategic rationale: focusing on core health insurance operations
The sale of World Nomads aligns with management’s stated objective to simplify the group’s portfolio and concentrate resources on core health insurance operations. By divesting the international travel brand, nib can channel capital toward its domestic health insurance and health-adjacent businesses, which represent the bulk of group earnings and strategic focus.
Management has emphasised its geographic focus on Australian and New Zealand markets, where regulatory expertise and established distribution networks provide competitive advantages. The divestment also reduces operational complexity, allowing nib to streamline reporting and management attention.
Notably, nib’s review of its remaining Australian and New Zealand travel insurance businesses is ongoing, flagging potential for further rationalisation. This suggests management may pursue additional divestments if assets do not meet strategic or financial thresholds.
Ed Close, nib Managing Director
“World Nomads is a strong brand with global recognition, and SiriusPoint and IMG bring significant sector experience, international scale and capital to support the next phase of its growth and development. We are confident IMG shares nib’s commitment to exceptional service, ensuring travellers are supported wherever they are in the world. It is business as usual for existing policyholders.”
Capital management review underway
nib will undertake a capital management review to determine the most effective use of proceeds from the sale. Potential uses include special dividends, share buybacks, debt reduction, or reinvestment in core operations. The outcome will be determined by management based on prevailing market conditions, balance sheet requirements, and strategic priorities.
The review provides optionality for shareholder returns or targeted reinvestment, with the final decision expected to be communicated following completion of the transaction and assessment of capital requirements across the group.
Transaction details and next steps
The transaction mechanics and timeline are structured as follows:
- Binding agreement signed with IMG, a wholly-owned subsidiary of SiriusPoint Ltd
- Transaction subject to regulatory approvals and customary completion conditions
- Majority of proceeds expected in CY26 following satisfaction of conditions
- nib to provide transitional support to IMG to ensure smooth and orderly handover of operations
- Existing World Nomads policyholders continue business as usual with minimal disruption
IMG, founded in 1990, is an award-winning global insurance benefits and assistance services company that has served millions of members worldwide. The company offers a wide range of insurance programmes, including international private medical insurance, travel medical insurance, and 24/7 emergency medical, security, and travel assistance.
SiriusPoint’s financial profile provides strong acquirer credentials. With approximately $2.8 billion total capital, SiriusPoint’s operating companies hold a financial strength rating of A- (Excellent) from AM Best, S&P, and Fitch, and A3 from Moody’s. The company is listed on the New York Stock Exchange (SPNT) and is Bermuda-headquartered with offices in New York, London, Stockholm, and other locations.
These credentials reduce execution risk and support an orderly transition, ensuring continuity for World Nomads customers and partners.
Upcoming catalyst: H1 FY26 results
nib Group will release its H1 FY26 results on Monday, 23 February 2026. This represents the next opportunity for investors to assess core business performance, updated guidance on portfolio strategy, and potential developments in the strategic review of remaining travel operations.
The results release may also provide further detail on the capital management review and allocation of proceeds from the World Nomads sale, offering clarity on management’s priorities for shareholder returns or reinvestment in core operations.
Get ASX Financial News Before the Market Reacts
Join 20,000+ investors receiving FREE breaking ASX announcements within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to stay ahead on financial sector news the moment it hits the market.